Qiagen NV | QIA - Selling And Administration Expenses

Stock Price
44.04
Daily Change
-0.03 -0.07%
Monthly
13.29%
Yearly
4.76%
Q1 Forecast
43.53

Qiagen NV reported $143.11M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Alaunos Therapeutics USD 585K 260K Sep/2025
argenx SE USD 336.29M 14.94M Sep/2025
Avita Medical AUD 20.98M 253K Jun/2025
Dianthus Therapeutics USD 8.2M 669K Sep/2025
Ionis Pharmaceuticals USD 86.56M 4.04M Sep/2025
IQVIA Holdings USD 514M 5M Sep/2025
Moderna USD 268M 38M Sep/2025
Organon & Co USD 399M 54M Sep/2025
Qiagen NV USD 143.11M 5.64M Sep/2025
Revvity USD 241.91M 9.6M Sep/2025
Tectonic Therapeutic USD 4.96M 190K Sep/2025
Viatris USD 886.6M 42.1M Sep/2025
Xeris Pharmaceuticals USD 46.46M 2.07M Sep/2025